OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer.

BACKGROUND: There is uncertainty about the chemotherapy sensitivity of some oestrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancers. Multiparameter assays that measure the expression of several tumour genes simultaneously have been developed to guide...

詳細記述

保存先:
書誌詳細
出版年:Health Technol Assess
主要な著者: Stein, Robert C, Dunn, Janet A, Bartlett, John Ms, Campbell, Amy F, Marshall, Andrea, Hall, Peter, Rooshenas, Leila, Morgan, Adrienne, Poole, Christopher, Pinder, Sarah E, Cameron, David A, Stallard, Nigel, Donovan, Jenny L, McCabe, Christopher, Hughes-Davies, Luke, Makris, Andreas
フォーマット: Artigo
言語:Inglês
出版事項: NIHR Journals Library 2016
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4781175/
https://ncbi.nlm.nih.gov/pubmed/26867046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3310/hta20100
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料